MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth

Journal of Clinical Investigation

Volumn 123, Issue 6, 2013, Pages 2703-2718

  Nemlich, Yael ^a,b   Greenberg, Eyal ^a,b   Ortenberg, Rona ^a,b   Besser, Michal J ^a,b   Barshack, Iris ^a   Jacob Hirsch, Jasmine ^a   Jacoby, Elad ^a   Eyal, Eran ^a   Rivkin, Ludmila ^c   Prieto, Victor G ^d   Chakravarti, Nitin ^d   Duncan, Lyn M ^e   Kallenberg, David M ^f   Galun, Eitan ^c   Bennett, Dorothy C ^f   Amariglio, Ninette ^a   Bar Eli, Menashe ^d   Schachter, Jacob ^a   Rechavi, Gideon ^a,b   Markel, Gal ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE DEAMINASE ACTING ON RNA 1 ENZYME; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; MICRORNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GENETICS; CANCER GROWTH; CARCINOGENICITY; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTATIC MELANOMA; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RNA BINDING; RNA EDITING; RNA PROCESSING; TISSUE MICROARRAY;

ADENOSINE DEAMINASE; ANIMALS; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; DEAD-BOX RNA HELICASES; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOMA; MICE; MICE, INBRED NOD; MICE, SCID; MICRORNAS; NEOPLASM TRANSPLANTATION; PREGNANCY PROTEINS; PROTEINS; RIBONUCLEASE III; RNA EDITING; RNA INTERFERENCE; TRANSCRIPTOME;

EID: 84878567131     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI62980     Document Type: Article

References (63)

1. Scholzová E, Malík R, Sevcík J, Kleibl Z. RNA regulation and cancer development. Cancer Lett. 2007;246(1-2):12-23.
2. Galeano F, Tomaselli S, Locatelli F, Gallo A. A-to-I RNA editing: The "ADAR" side of human cancer. Semin Cell Dev Biol. 2012;23(3):244-250.
3. Paz N, et al. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res. 2007; 17(11):1586-1595.
4. Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem. 2010;79:321-349.
5. Keegan LP, Gallo A, O'Connell MA. The many roles of an RNA editor. Nat Rev Genet. 2001;2(11):869-878.
6. Keegan LP, Leroy A, Sproul D, O'Connell MA. Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes. Genome Biol. 2004;5(2):209.
7. Valente L, Nishikura K. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. In: Kivie M, ed. Progress in Nucleic Acid Research and Molecular Biology. Waltham, Massachusetts, USA: Academic Press; 2005:299-338.
8. Dominissini D, Moshitch-Moshkovitz S, Amariglio N, Rechavi G. Adenosine-to-inosine RNA editing meets cancer. Carcinogenesis. 2011;32(11):1569-1577.
9. Iizasa H, Nishikura K. A new function for the RNA-editing enzyme ADAR1. Nat Immunol. 2009; 10(1):16-18.
10. XuFeng R, et al. ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proc Natl Acad Sci U S A. 2009;106(42):17763-17768.
11. Wulff BE, Nishikura K. Modulation of microRNA expression and function by ADARs. Curr Top Microbiol Immunol. 2012;353:91-109.
12. Zinshteyn B, Nishikura K. Adenosine-to-inosine RNA editing. Wiley Interdiscip Rev Syst Biol Med. 2009;1(2):202-209.
13. Heale BSE, et al. Editing independent effects of ADARs on the miRNA/siRNA pathways. EMBO J. 2009;28(20):3145-3156.
14. Galeano F, et al. Human BLCAP transcript: new editing events in normal and cancerous tissues. Int J Cancer. 2010;127(1):127-137.
15. Levanon EY, et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotech. 2004;22(8):1001-1005.
16. Levanon EY, et al. Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Research. 2005;33(4):1162-1168.
17. Lai F, Drakas R, Nishikura K. Mutagenic analysis of double-stranded RNA adenosine deaminase, a candidate enzyme for RNA editing of glutamategated ion channel transcripts. J Biol Chem. 1995; 270(29):17098-17105.
18. Cancer Research Center at Sheba. Down-Regulated. Sheba Web site. http://sheba-cancer.org.il/yael/mirs-down/down.html. Accessed April 2, 2013.
19. Cancer Research Center at Sheba. Up-Regulated. Sheba Web site. http://sheba-cancer.org.il/yael/mirs-up/up.html. Accessed April 2, 2013.
20. Lewis BP, ShihIhJones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115(7):787-798.
21. Krichevsky AM, Gabriely G. miR-21: a small multifaceted RNA. J Cell Mol Med. 2009;13(1):39-53.
22. Greenberg E, et al. Regulation of cancer aggressive features in melanoma cells by microRNAs. PLoS One. 2011;6(4):e18936.
23. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597-610.
24. Jakymiw A, et al. Overexpression of dicer as a result of reduced let-7 microRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer. 2010;49(6):549-559.
25. Forman JJ, Legesse-Miller A, Coller HA. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A. 2008; 105(39):14879-14884.
26. Paroo Z, Ye X, Chen S, Liu Q. Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell. 2009;139(1):112-122.
27. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455(7209):58-63.
28. Tokumaru S, Suzuki M, Yamada H, Nagino M, Takahashi T. let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis. 2008;29(11):2073-2077.
29. Fritz J, Strehblow A, Taschner A, Schopoff S, Pasierbek P, Jantsch MF. RNA-regulated interaction of transportin-1 and exportin-5 with the doublestranded RNA-binding domain regulates nucleocytoplasmic shuttling of ADAR1. Mol Cell Biol. 2009;29(6):1487-1497.
30. Nie Y, Ding L, Kao PN, Braun R, Yang J-H. ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing. Mol Cell Biol. 2005; 25(16):6956-6963.
31. Wang Y, Samuel CE. Adenosine deaminase ADAR1 increases gene expression at the translational level by decreasing protein kinase PKR-dependent eIF-2alpha phosphorylation. J Mol Biol. 2009; 393(4):777-787.
32. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005; 6(5):376-385.
33. Olive V, Jiang I, He L. mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol. 2010;42(8):1348-1354.
34. Seitz H, et al. Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene. Nat Genet. 2003;34(3):261-262.
35. Gommans WM, Maas S. Characterization of ADAR1-mediated modulation of gene expression. Biochem Biophys Res Commun. 2008;377(1):170-175.
36. Samuel CE. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology. 2011;411(2):180-193.
37. Wang Q, et al. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem. 2004;279(6):4952-4961.
38. Nishikura K. Editor meets silencer: crosstalk between RNA editing and RNA interference. Nat Rev Mol Cell Biol. 2006;7(12):919-931.
39. Amariglio N, Rechavi G. A-to-I RNA editing: A new regulatory mechanism of global gene expression. Blood Cells Mol Dis. 2007;39(2):151-155.
40. Cenci C, et al. Down-regulation of RNA editing in pediatric astrocytomas. J Biol Chem. 2008; 283(11):7251-7260.
41. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008;132(3):363-374.
42. Wang H, Hou Z, Wu Y, Ma X, Luo X. p150 ADAR1 isoform involved in maintenance of HeLa cell proliferation. BMC Cancer. 2006;6:282.
43. Shah SP, et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature. 2009;461(7265):809-813.
44. Ma C-H, et al. Abnormal expression of ADAR1 isoforms in Chinese pediatric acute leukemias. Biochem Biophys Res Commun. 2011;406(2):245-251.
45. Hartner JC, Walkley CR, Lu J, Orkin SH. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol. 2009;10(1):109-115.
46. Kawahara Y, Zinshteyn B, Chendrimada TP, Shiekhattar R, Nishikura K. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep. 2007;8(8):763-769.
47. Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou AG, Nishikura K. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science. 2007;315(5815):1137-1140.
48. Yang W, et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol. 2006;13(1):13-21.
49. Alon S, et al. Systematic identification of edited microRNAs in the human brain. Genome Res. 2012; 22(8):1533-1540.
50. Kawahara Y, et al. Frequency and fate of microRNA editing in human brain. Nucleic Acids Research. 2008;36(16):5270-5280.
51. Fierro-Monti I, Mathews MB. Proteins binding to duplexed RNA: one motif, multiple functions. Trends Biochem Sci. 2000;25(5):241-246.
52. George CX, Gan Z, Liu Y, Samuel CE. Adenosine deaminases acting on RNA, RNA editing, and interferon action. J Interferon Cytokine Res. 2011; 31(1):99-117.
53. Herbert A, et al. The Zα domain from human ADAR1 binds to the Z-DNA conformer of many different sequences. Nucleic Acids Research. 1998; 26(15):3486-3493.
54. Sakamoto S, et al. The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway. Mol Cell Biol. 2009;29(13):3754-3769.
55. Ernst A, et al. De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Oncogene. 2010; 29(23):3411-3422.
56. Ren J, et al. DNA hypermethylation as a chemotherapy target. Cell Sig. 2011;23(7):1082-1093.
57. Agirre X, Martínez-Climent JÁ, Odero MD, Prósper F. Epigenetic regulation of miRNA genes in acute leukemia. Leukemia. 2012;26(3):395-403.
58. da Rocha ST, Edwards CA, Ito M, Ogata T, Ferguson-Smith AC. Genomic imprinting at the mammalian Dlk1-Dio3 domain. Trends Genet. 2008; 24(6):306-316.
59. Besser MJ, et al. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin Cancer Res. 2010;16(9):2646-2655.
60. Markel G, et al. Systemic dysregulation of CEACAM1 in melanoma patients. Cancer Immunol Immunother. 2010;59(2):215-230.
61. Koren-Michowitz M, et al. A new MALDI-TOFbased assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD). Leuk Res. 2008;32(3):421-427.
62. Parisien M, Major F. The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data. Nature. 2008;452(7183):51-55.
63. Pall GS, Hamilton AJ. Improved northern blot method for enhanced detection of small RNA. Nat Protoc. 2008;3(6):1077-1084.